Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus. [electronic resource]
Producer: 20050711Description: 435-44 p. digitalISSN:- 0263-6352
- Adult
- Aged
- Albuminuria -- drug therapy
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Angiotensin-Converting Enzyme Inhibitors -- pharmacology
- Arteriosclerosis -- drug therapy
- Benzimidazoles -- adverse effects
- Biomarkers -- blood
- Biphenyl Compounds -- adverse effects
- Blood Pressure -- drug effects
- Diabetes Mellitus, Type 2 -- complications
- Double-Blind Method
- Enalapril -- adverse effects
- Female
- Fibrinogen -- analysis
- Humans
- Hypertension -- drug therapy
- Intercellular Adhesion Molecule-1 -- blood
- Male
- Middle Aged
- Plasminogen Activator Inhibitor 1 -- blood
- Tetrazoles -- adverse effects
- Vascular Cell Adhesion Molecule-1 -- blood
- von Willebrand Factor -- analysis
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.